Bayhill Therapeutics
Bayhill Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics for.
Launch date
Employees
Market cap
-
Enterprise valuation
€36—55m (Dealroom.co estimates Jul 2009.)
Portola Valley California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Series A | ||
$35.4m | Series B | ||
N/A | $10.0m | Early VC | |
Total Funding | €41.3m |